339.This Month in Medtech: $21B Deals, Cardiovascular Boom & AI Surges

In this episode, Nicholas Talamantes, Sr. Director of Market Intelligence at Life Science Intelligence (LSI), breaks down the transformative end to 2025 in medtech. We dissect the M&A surge, the critical trends in cardiovascular innovation, and the Q3 earnings that signal a blockbuster 2026. Tune in for the strategic insights every founder and investor needs.Episode Breakdown00:00 – Opening Message: Focus, Confidence & Medtech Momentum 00:56 – Welcome Back: This Month in MedTech (November Edition) 02:00 – Thanksgiving Week Stories & Book Recommendations 03:25 – AI Boom or Bubble? Market Signals & Big Players Moving 06:00 – Tech Bubble Talk: Nvidia, Palantir & Investor Behavior 07:20 – Not a Tech Podcast… Switching to Medtech News 08:00 – November’s Huge M&A Wave (Abbott + Exact Sciences) 09:20 – Strategic Focus: Tuck-Ins, Diagnostics & Oncology Moves 12:10 – Mini-Strategics Are Changing Medtech (Omar’s Thesis) 17:15 – GE Healthcare + Intelerad: AI Imaging Expansion 19:30 – GE Healthcare Growth Strategy & Market Position 21:10 – 2025 Medtech M&A Snapshot- Deals, Values & Trends 22:30 – Why Tuck-Ins Dominate & Average Deal Sizes Explained 25:30 – Cardiovascular Market Intro: $70B & Surging 27:10 – Why Cardio Remains Medtech’s Biggest Opportunity 28:10 – Heart Failure: 500M Patients & AI’s New Role 30:00 – Continuous Monitoring & AI Adoption in Cardiology 31:20 – Nvidia’s Role in Medtech (Partnerships vs Investments) 33:00 – How AI Devices Are Transforming Cardio Care 34:00 – Renal Denervation: CMS Approval & 17% CAGR 35:45 – Medtronic vs Boston Scientific in Renal Denervation 38:40 – Connected Monitoring & “Cardiology Without Walls” 39:20 – AI as a Clinical Tool, Not Just Workflow Enhancement 40:30 – iRhythm Visit Teaser & Stunning Profit Margins 42:35 – Sidebar: Apple vs Masimo- Patent Battle Explained 44:10 – Joe Kiani’s Advice: Never Give Up Control of Your Company 46:00 – Apple’s Absurd M&A History (Beats by Dre = Largest Deal) 49:20 – Q3 Earnings Overview: Strongest Quarter of the Year 50:10 – Abbott, Boston Sci, Edwards, Stryker Performance 52:00 – Siemens & J&J Medtech Updates 53:00 – Intuitive Surgical Still Dominating (23% YoY) 54:20 – The Robotics Battle: Da Vinci vs New Entrants 55:15 – Deals of the Month (November) Rundown 58:10 – Key Insight: Medtech Is Doubling Down on Focus 59:10 – Advice for Founders: What Strategics Want in 2026 01:00:00 – How to Use MarketCraft & Mini-Strategic Framework 01:00:35 – Closing Thoughts, Thanksgiving Wishes & Call to Action Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channel⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Subscribe to our LinkedIn Newsletter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.stateofmedtechpodcast.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow The State of MedTech onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/company/thestateofmedtech⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtech⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/StateofMedTech⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@omarkhateebofficial⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/OmarMKhateeb⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠#MedTech #HealthTech #Cardiology #...